15 нояб. 2023 г. · The objective of this guideline is to help healthcare professionals diagnose and manage patients with cardiomyopathies of all ages according to the best ... |
The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy provides recommendations to guide clinicians in the ... |
8 мая 2024 г. · The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy provides recommendations to guide clinicians. |
The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy provides recommendations to guide clinicians. |
Numerous guidelines on the diagnosis and management of hypertrophic cardiomyopathy (HCM) have been published, by learned societies, over the past decade. |
Hypertrophic cardiomyopathy (HCM) is defined by the presence of increased left ventricular (LV) wall thickness that is not solely explained by abnormal loading ... |
10 мая 2024 г. · A working group reviewed evidence published since the 2020 guideline and updated recommendations for diagnosis and management of hypertrophic cardiomyopathy ( ... |
01205-8/asset/7d2e5e42-ca9f-4558-888f-c903b4695b3d/main.assets/gr3_lrg.jpg)
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |